Skip to content

Evaluation of Pain Sensitivity and Neuroresponse after Cobotide Treatment in Neurodegenerative Populations

Evaluation of Pain Sensitivity and Neuroresponse after Cobotide Treatment in Neurodegenerative Populations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112101
Enrollment
Unknown
Registered
2025-11-10
Start date
2025-11-30
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodegenerative diseases

Interventions

Observation group:None

Sponsors

Xiangya Hospital Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age limit between 35 and 85 years old, complete clinical data, ability to read and understand the contents of the study scale, consent of patients and their families, voluntary signing of informed consent form.

Exclusion criteria

Exclusion criteria: Incomplete clinical data, accompanied by blindness, deafness, severe language disorders, etc. can not cooperate with cognitive function examination.

Design outcomes

Primary

MeasureTime frame
Numerical rating scale, NRS;Visual analogue scale,VAS;Wong-Baker faces pain scale revision, FPS-R;

Secondary

MeasureTime frame
Montreal Cognitive Assessment, MoCA;Activity of Daily Living Scale,ADL;Quantitative Sensory Testing,QST;Selective Functional Movement Assessment,SFMA;Depression Anxiety and Stress Scale,DASS-21;

Countries

China

Contacts

Public ContactXiao Jian

Xiangya Hospital Central South University

admanoas@163.com+86 139 7316 8895

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026